SIBN
SI-BONE, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$18.57
−0.38%Year over year
Reported trailing growth
- Revenue
- +15.3%
- EBITDA
- +68.4%
- EBIT
- +35.7%
- EPS
- +39.3%
- Free cash flow
- +65.5%
- Operating cash flow
- +176.1%
Forward estimates
Based on analyst estimates
- Revenue
- +17.3%
- EBITDA
- -47.0%
- EPS
- -16.9%
Three-year CAGR
- Revenue
- +23.6%
- EBITDA
- +52.8%
- EBIT
- +36.6%
- Net income
- +38.8%
- EPS
- +41.3%
- Free cash flow
- +60.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026